{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:03:41Z","timestamp":1772881421233,"version":"3.50.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1097\/mph.0000000000000208","type":"journal-article","created":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T12:34:29Z","timestamp":1404477269000},"page":"e41-e44","source":"Crossref","is-referenced-by-count":4,"title":["Diffuse Hemorrhagic Colitis in a Patient With Dyskeratosis Congenita After Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1097","volume":"37","author":[{"given":"Karoline","family":"Ehlert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Rossig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas H.","family":"Groll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Beyna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Froehlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heribert","family":"Juergens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-26-20210209","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/GIM.0b013e3181f415b5","article-title":"The genetics and clinical manifestations of telomere biology disorders.","volume":"12","author":"Savage","year":"2010","journal-title":"Genet Med"},{"key":"R2-26-20210209","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00439-013-1265-8","article-title":". Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in dyskeratosis congenita.","volume":"132","author":"Ballew","year":"2013","journal-title":"Hum Genet"},{"key":"R3-26-20210209","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3324\/haematol.2012.071068","article-title":". Mutations in the telomere capping complex in bone marrow failure and related syndromes.","volume":"98","author":"Walne","year":"2013","journal-title":"Haematol"},{"key":"R4-26-20210209","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/sj.bmt.1705171","article-title":". Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen.","volume":"36","author":"Brazzola","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"R5-26-20210209","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.bmt.1705839","article-title":". Late death after unrelated-BMT for dyskeratosis congenital following conditioning with alemtuzumab, fludarabine and melphalan.","volume":"40","author":"Amarasinghe","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"R6-26-20210209","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/bmt.2010.65","article-title":". Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.","volume":"46","author":"Dietz","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"R7-26-20210209","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2141.2008.07364.x","article-title":". Double cord blood transplantation in patients with high risk bone marrow failure syndromes.","volume":"143","author":"Ruggeri","year":"2008","journal-title":"Br J Haematol"},{"key":"R8-26-20210209","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1365-2141.2002.03822.x","article-title":". A novel DKC1 mutation, severe combined immunodeficiency (TB-NK-SCID) and bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndrome.","volume":"119","author":"Cossu","year":"2002","journal-title":"Br J Haematol"},{"key":"R9-26-20210209","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.bmt.1701567","article-title":". Correction of bone marrow failure in dyskeratosis congenital by bone marrow transplantation.","volume":"23","author":"Ghavamzadeh","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"R10-26-20210209","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/pbc.20696","article-title":". Allogeneic stem cell transplantation in a patient with dyskeratosis congenita after conditioning with low-dose cyclophosphamide and anti-thymocyte globulin.","volume":"49","author":"Ayas","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R11-26-20210209","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.bmt.1703844","article-title":". Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of dyskeratosis congenita.","volume":"31","author":"Gungor","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R12-26-20210209","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bbmt.2006.11.015","article-title":". Fludarabine, cyclophoshamide, and antithymocyte globulin for a patient with dyskeratosis congenital and severe bone marrow failure.","volume":"13","author":"Ostronoff","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R13-26-20210209","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1365-2141.2002.03835_2.x","article-title":". Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine-based reduced-intensity conditioning regimen.","volume":"119","author":"Nobili","year":"2002","journal-title":"Br J Haematol"},{"key":"R15-26-20210209","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1365-2141.1996.424984.x","article-title":". Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita.","volume":"92","author":"Langston","year":"1996","journal-title":"Br J Haematol"},{"key":"R16-26-20210209","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0140-6736(09)60945-4","article-title":". Haematopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 12 study.","volume":"374","author":"Straathof","year":"2009","journal-title":"Lancet"},{"key":"R17-26-20210209","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/sj.bmt.1703931","article-title":". Low-intensity stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita.","volume":"31","author":"Dror","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R18-26-20210209","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/bmt.2008.163","article-title":". Unrelated cord blood transplantation in a girl with Hoyeraal-Hreidarsson syndrome.","volume":"42","author":"Coman","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"R19-26-20210209","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.bmt.1700674","article-title":". Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation.","volume":"19","author":"Yabe","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"R20-26-20210209","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bbmt.2013.05.021","article-title":". Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.","volume":"19","author":"Gadalla","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"R21-26-20210209","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1601-5037.2009.00364.x","article-title":"Dyskeratosis congenita: clinical report and review of the literature.","volume":"8","author":"Baran","year":"2010","journal-title":"Int J Dent Hyg"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000000208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:45:34Z","timestamp":1620963934000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201501000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000208","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}